Molecular radiation biology/oncology at its best: Cutting edge research presented at the 13th International Wolfsberg Meeting on Molecular Radiation Biology/Oncology

Radiotherapy and Oncology

Volumn 108, Issue 3, 2013, Pages 357-361

  Baumann, Michael ^a   Bodis, Stephan ^b   Dikomey, Ekkehard ^c   Van Der Kogel, Albert ^d   Overgaard, Jens ^e   Rodemann, Hans Peter ^f   Wouters, Bradly ^g  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b CANTONAL HOSPITAL AARAU   (Switzerland)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e AARHUS UNIVERSITY HOSPITAL   (Denmark)

^f UNIVERSITY OF TÜBINGEN   (Germany)

^g PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ATM PROTEIN; BIOLOGICAL MARKER; CHEMOKINE RECEPTOR CXCR4; CHLOROQUINE; CYCLIN DEPENDENT KINASE 1; CYCLIN DEPENDENT KINASE 2; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; MICRORNA; MIRNA 335; MITOGEN ACTIVATED PROTEIN KINASE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR SNAIL; UNCLASSIFIED DRUG;

AUTOPHAGY; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RESEARCH; CANCER STEM CELL; CANCER TISSUE; CELL GROWTH; CELL MIGRATION; CELL POPULATION; CELL SURVIVAL; CELLULAR DISTRIBUTION; CLINICAL RESEARCH; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DOUBLE STRANDED DNA BREAK; DRUG EFFICACY; HEAD AND NECK CANCER; HOMOLOGOUS RECOMBINATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LYMPH NODE METASTASIS; MOLECULAR BIOLOGY; NEOPLASM; ONCOLOGY; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION ONCOLOGIST; RADIOBIOLOGY; RADIOSENSITIVITY; RADIOSENSITIZATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; TUMOR CELL; TUMOR MICROENVIRONMENT; UTERINE CERVIX CANCER;

BIOLOGICAL MARKERS; DNA DAMAGE; HUMANS; NEOPLASMS; RADIOBIOLOGY; SIGNAL TRANSDUCTION;

EID: 84887004029     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.10.001     Document Type: Editorial

References (130)

1. K. Dittmann, C. Mayer, and B. Fehrenbacher Nuclear epidermal growth factor receptor modulates cellular radio-sensitivity by regulation of chromatin access Radiother Oncol 99 2011 317 322
2. I. Eke, and N. Cordes Dual targeting of EGFR and focal adhesion kinase in 3D grown HNSCC cell cultures Radiother Oncol 99 2011 279 286
3. K. Gurtner, Y. Deuse, and R. Butof Diverse effects of combined radiotherapy and EGFR inhibition with antibodies or TK inhibitors on local tumour control and correlation with EGFR gene expression Radiother Oncol 99 2011 323 330
4. C. Halle, M. Lando, and K. Sundfor Phosphorylation of EGFR measured with in situ proximity ligation assay: relationship to EGFR protein level and gene dosage in cervical cancer Radiother Oncol 101 2011 152 157
5. B. Jutten, T.G. Keulers, and M.B. Schaaf EGFR overexpressing cells and tumors are dependent on autophagy for growth and survival Radiother Oncol 2013 [epub ahead of print]
6. L. Myllynen, T. Rieckmann, and J. Dahm-Daphi In tumor cells regulation of DNA double strand break repair through EGF receptor involves both NHEJ and HR and is independent of p53 and K-Ras status Radiother Oncol 101 2011 147 151
7. M. Toulany, T.A. Schickfluss, and K.R. Fattah Function of erbB receptors and DNA-PKcs on phosphorylation of cytoplasmic and nuclear Akt at S473 induced by erbB1 ligand and ionizing radiation Radiother Oncol 101 2011 140 146
8. M. Toulany, K.J. Lee, and K.R. Fattah Akt promotes post-irradiation survival of human tumor cells through initiation, progression, and termination of DNA-PKcs-dependent DNA double-strand break repair Mol Cancer Res 10 2012 945 957
9. M. Kriegs, U. Kasten-Pisula, and T. Rieckmann The epidermal growth factor receptor modulates DNA double-strand break repair by regulating non-homologous end-joining DNA Repair 9 2010 889 897
10. M. Saki, M. Toulany, and H.P. Rodemann Acquired resistance to cetuximab is associated with the overexpression of Ras family members and the loss of radiosensitization in head and neck cancer cells Radiother Oncol 108 2013 473 478
11. P.A. Jeggo, V. Geuting, and M. Lobrich The role of homologous recombination in radiation-induced double-strand break repair Radiother Oncol 101 2011 7 12
12. N.T. Martin, S.A. Nahas, and R. Tunuguntla Assessing 'radiosensitivity' with kinetic profiles of gamma-H2AX, 53BP1 and BRCA1 foci Radiother Oncol 101 2011 35 38
13. P.L. Olive Retention of gammaH2AX foci as an indication of lethal DNA damage Radiother Oncol 101 2011 18 23
14. A.C. Parplys, E. Petermann, and C. Petersen DNA damage by X-rays and their impact on replication processes Radiother Oncol 102 2012 466 471
15. J. Bentley, C.P. Diggle, and P. Harnden DNA double strand break repair in human bladder cancer is error prone and involves microhomology-associated end-joining Nucleic Acids Res 32 2004 5249 5259
16. L.A. Tobin, C. Robert, and P. Nagaria Targeting abnormal DNA repair in therapy-resistant breast cancers Mol Cancer Res 10 2012 96 107
17. X. Guo, C. Yang, and X. Qian Estrogen Receptor alpha Regulates ATM Expression through miRNAs in Breast Cancer Clin Cancer Res 2013 [epub ahead of print]
18. R.J. Boohaker, X. Cui, and M. Stackhouse ATM-mediated Snail Serine 100 phosphorylation regulates cellular radiosensitivity Radiother Oncol 108 2013 403 408
19. N. Tomimatsu, B. Mukherjee, and K. Deland Exo1 plays a major role in DNA end resection in humans and influences double-strand break repair and damage signaling decisions DNA Repair 11 2012 441 448
20. M. Lando, S.M. Wilting, and K. Snipstad Identification of eight candidate target genes of the recurrent 3p12-p14 loss in cervical cancer by integrative genomic profiling J Pathol 230 2013 59 69
21. S.A. Weppler, Y. Li, and L. Dubois Expression of EGFR variant vIII promotes both radiation resistance and hypoxia tolerance Radiother Oncol 83 2007 333 339
22. H. Chaachouay, P. Ohneseit, and M. Toulany Autophagy contributes to resistance of tumor cells to ionizing radiation Radiother Oncol 99 2011 287 292
23. A. Apel, I. Herr, and H. Schwarz Blocked autophagy sensitizes resistant carcinoma cells to radiation therapy Cancer Res 68 2008 1485 1494
24. J. Vignard, G. Mirey, and B. Salles Ionizing-radiation induced DNA double-strand breaks: A direct and indirect lighting up Radiother Oncol 108 2013 362 369
25. E.P. Rogakou, D.R. Pilch, and A.H. Orr DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139 J Biol Chem 273 1998 5858 5868
26. F. Bouquet, M. Ousset, and D. Biard A DNA-dependent stress response involving DNA-PK occurs in hypoxic cells and contributes to cellular adaptation to hypoxia J Cell Sci 124 2011 1943 1951
27. P. Reynolds, J.A. Anderson, and J.V. Harper The dynamics of Ku70/80 and DNA-PKcs at DSBs induced by ionizing radiation is dependent on the complexity of damage Nucleic Acids Res 40 2012 10821 10831
28. T. Helleday The underlying mechanism for the PARP and BRCA synthetic lethality: clearing up the misunderstandings Mol Oncol 5 2011 387 393
29. J.F. Hilton, M.J. Hadfield, and M.T. Tran Poly(ADP-ribose) polymerase inhibitors as cancer therapy Front Biosci 18 2013 1392 1406
30. G. Papeo, E. Casale, and A. Montagnoli PARP inhibitors in cancer therapy: an update Expert Opin Ther Pat 23 2013 503 514
31. A.J. Chalmers, M. Lakshman, and N. Chan Poly(ADP-ribose) polymerase inhibition as a model for synthetic lethality in developing radiation oncology targets Semin Radiat Oncol 20 2010 274 281
32. L.S. Symington, and J. Gautier Double-strand break end resection and repair pathway choice Annu Rev Genet 45 2011 247 271
33. L.P. Ferretti, L. Lafranchi, and A.A. Sartori Controlling DNA-end resection: a new task for CDKs Front Genet 4 2013 99
34. H. Hu, L. Du, and G. Nagabayashi ATM is down-regulated by N-Myc-regulated microRNA-421 Proc Natl Acad Sci USA 107 2010 1506 1511
35. W.Y. Mansour, N.V. Bogdanova, and U. Kasten-Pisula Aberrant overexpression of miR-421 downregulates ATM and leads to a pronounced DSB repair defect and clinical hypersensitivity in SKX squamous cell carcinoma Radiother Oncol 106 2013 147 154
36. N.T. Martin, K. Nakamura, and R. Davies ATM-dependent MiR-335 targets CtIP and modulates the DNA damage response PLoS Genet 9 2013 e1003505
37. D.J. Richard, E. Bolderson, and L. Cubeddu Single-stranded DNA-binding protein hSSB1 is critical for genomic stability Nature 453 2008 677 681
38. W. Shi, A.L. Bain, and B. Schwer Essential developmental, genomic stability, and tumour suppressor functions of the mouse orthologue of hSSB1/NABP2 PLoS Genet 9 2013 e1003298
39. U. Koch, M. Krause, and M. Baumann Cancer stem cells at the crossroads of current cancer therapy failures-radiation oncology perspective Semin Cancer Biol 20 2010 116 124
40. J. Salendo, M. Spitzner, and F. Kramer Identification of a microRNA expression signature for chemoradiosensitivity of colorectal cancer cells, involving miRNAs-320a, -224, -132 and let7g Radiother Oncol 108 2013 451 457
41. A. Güttler, M. Giebler, and P. Cuno Osteopontin and splice variant expression level in human malignant glioma: radiobiologic effects and prognosis after radiotherapy Radiother Oncol 108 2013 535 540
42. A. DalPra, E. Lalonde, and J. Sykes TMPRSS2-ERG status is not prognostic following prostate cancer radiotherapy: implications for fusion status and DSB repair Clin Cancer Res 2013 [in press]
43. M.F. Clarke, J.E. Dick, and P.B. Dirks Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells Cancer Res 66 2006 9339 9344
44. M. Baumann, M. Krause, and R. Hill Exploring the role of cancer stem cells in radioresistance Nat Rev Cancer 8 2008 545 554
45. D. Dingli, and F. Michor Successful therapy must eradicate cancer stem cells Stem Cells 24 2006 2603 2610
46. M. Baumann, M. Krause, H. Thames, K. Trott, and D. Zips Cancer stem cells and radiotherapy Int J Radiat Biol 85 2009 391 402
47. R. Bütof, A. Dubrovska, and M. Baumann Clinical perspectives of cancer stem cell research in radiation oncology Radiother Oncol 2013 [in press]
48. T.B. Brunner, L.A. Kunz-Schughart, P. Grosse-Gehling, and M. Baumann Cancer stem cells as a predictive factor in radiotherapy Semin Radiat Oncol 22 2012 151 174
49. C. Peitzsch, I. Kurth, L. Kunz-Schughart, M. Baumann, and A. Dubrovska Discovery of the cancer stem cell related determinants of radioresistance Radiother Oncol 108 2013 378 387
50. J. Mihatsch, M. Toulany, and P.M. Bareiss Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro Radiother Oncol 99 2011 300 306
51. F.P. D'Andrea, A. Safwat, M. Kassem, L. Gautier, J. Overgaard, and M.R. Horsman Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance Radiother Oncol 99 2011 373 378
52. X. Zhang, B. Fang, R. Mohan, and J.Y. Chang Coxsackie-adenovirus receptor as a novel marker of stem cells in treatment-resistant non-small cell lung cancer Radiother Oncol 105 2012 250 257
53. S. Skvortsov, C.R. Jimenez, and J.C. Knol Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets Radiother Oncol 101 2011 177 182
54. J.K. Smit, H. Faber, and M. Niemantsverdriet Prediction of response to radiotherapy in the treatment of esophageal cancer using stem cell markers Radiother Oncol 107 2013 434 441
55. M. Shibata, and M.M. Shen The roots of cancer: stem cells and the basis for tumor heterogeneity Bioessays 35 2013 253 260
56. N. Navin, J. Kendall, and J. Troge Tumour evolution inferred by single-cell sequencing Nature 472 2011 90 94
57. A. Sottoriva, I. Spiteri, and S.G. Piccirillo Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics Proc Natl Acad Sci USA 110 2013 4009 4014
58. A. Sottoriva, I. Spiteri, D. Shibata, C. Curtis, and S. Tavare Single-molecule genomic data delineate patient-specific tumor profiles and cancer stem cell organization Cancer Res 73 2013 41 49
59. S. Lettmaier, M. Lotter, S. Kreppner, A. Strnad, R. Fietkau, and V. Strnad Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer Radiother Oncol 104 2012 181 186
60. S. Huang, C. Li, and E.A. Armstrong Dual targeting of EGFR and HER3 with MEHD7945A overcomes acquired resistance to EGFR inhibitors and radiation Cancer Res 73 2013 824 833
61. C.N. Andreassen, J. Alsner, M. Overgaard, and J. Overgaard Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes Radiother Oncol 69 2003 127 135
62. C.N. Andreassen, J. Alsner, M. Overgaard, F.B. Sorensen, and J. Overgaard Risk of radiation-induced subcutaneous fibrosis in relation to single nucleotide polymorphisms in TGFB1, SOD2, XRCC1, XRCC3, APEX and ATM-a study based on DNA from formalin fixed paraffin embedded tissue samples Int J Radiat Biol 82 2006 577 586
63. C.N. Andreassen, J. Overgaard, and J. Alsner ATM sequence variants and risk of radiation-induced subcutaneous fibrosis after postmastectomy radiotherapy Int J Radiat Oncol Biol Phys 64 2006 776 783
64. O.K. Rødningen, A.L. Borresen-Dale, J. Alsner, T. Hastie, and J. Overgaard Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis Radiother Oncol 86 2008 314 320
65. J. Alsner, O.K. Rødningen, and J. Overgaard Differential gene expression before and after ionizing radiation of subcutaneous fibroblasts identifies breast cancer patients resistant to radiation-induced fibrosis Radiother Oncol 83 2007 261 266
66. H. Muaddi, S. Chowdhury, R. Vellanki, P. Zamiara, and M. Koritzinsky Contributions of AMPK and p53 dependent signaling to radiation response in the presence of metformin Radiother Oncol 108 2013 446 450
67. Y. Storozhuk, S.N. Hopmans, T. Sanli, C. Barron, E. Tsiani, and J.-C. Cutz Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPK Br J Cancer 108 2013 2021 2032
68. H.D. Skinner, M.R. McCurdy, A.E. Echeverria, S.H. Lin, J.W. Welsh, and M.S. O'Reilly Metformin use and improved response to therapy in esophageal adenocarcinoma Acta Oncol 52 2013 1002 1009
69. T. Sanli, A. Rashid, C. Liu, S. Harding, R.G. Bristow, and J.-C. Cutz Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells Int J Radiat Oncol Biol Phys 78 2010 221 229
70. C.W. Song, H. Lee, R.P.M. Dings, B. Williams, J. Powers, and T.D. Santos Metformin kills and radiosensitizes cancer cells and preferentially kills cancer stem cells Sci Rep 2 2012 362
71. N. Chaudary, H. Mujcic, B.G. Wouters, and R.P. Hill Hypoxia and metastasis in an orthotopic cervix cancer xenograft model Radiother Oncol 108 2013 506 510
72. J.T. Erler, K.L. Bennewith, M. Nicolau, N. Dornhöfer, C. Kong, and Q.-T. Le Lysyl oxidase is essential for hypoxia-induced metastasis Nature 440 2006 1222 1226
73. H. Kanao, T. Enomoto, T. Kimura, M. Fujita, R. Nakashima, and Y. Ueda Overexpression of LAMP3/TSC403/DC-LAMP promotes metastasis in uterine cervical cancer Cancer Res 65 2005 8640 8645
74. P. Subarsky, and R.P. Hill The hypoxic tumour microenvironment and metastatic progression Clin Exp Metastasis 20 2003 237 250
75. D. Cojocari, R.N. Vellanki, B. Sit, D. Uehling, M. Koritzinsky, and B.G. Wouters New small molecule inhibitors of UPR activation demonstrate that PERK, but not IRE1α signaling is essential for promoting adaptation and survival to hypoxia Radiother Oncol 108 2013 541 547
76. H. Mujcic, T. Rzymski, K.M.A. Rouschop, M. Koritzinsky, M. Milani, and A.L. Harris Hypoxic activation of the unfolded protein response (UPR) induces expression of the metastasis-associated gene LAMP3 Radiother Oncol 92 2009 450 459
77. B.G. Wouters, and M. Koritzinsky Hypoxia signalling through mTOR and the unfolded protein response in cancer Nat Rev Cancer 8 2008 851 864
78. K.M. Rouschop, L.J. Dubois, T.G. Keulers, T. van den Beucken, P. Lambin, and J. Bussink PERK/eIF2α signaling protects therapy resistant hypoxic cells through induction of glutathione synthesis and protection against ROS PNAS 110 2013 4622 4627
79. S. Anbalagan, I.M. Pires, C. Blick, M.A. Hill, D.J.P. Ferguson, and D.A. Chan Radiosensitization of renal cell carcinoma in vitro through the induction of autophagy Radiother Oncol 103 2012 388 393
80. H. Chaachouay, P. Ohneseit, M. Toulany, R. Kehlbach, G. Multhoff, and H.P. Rodemann Autophagy contributes to resistance of tumor cells to ionizing radiation Radiother Oncol 99 2011 287 292
81. K.M.A. Rouschop, C.H.M.A. Ramaekers, M.B.E. Schaaf, T.G.H. Keulers, K.G.M. Savelkouls, and P. Lambin Autophagy is required during cycling hypoxia to lower production of reactive oxygen species Radiother Oncol 92 2009 411 416
82. K.M.A. Rouschop, T. van den Beucken, L. Dubois, H. Niessen, J. Bussink, and K. Savelkouls The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5 J Clin Invest 120 2010 127 141
83. M.B.E. Schaaf, D. Cojocari, T.G. Keulers, B. Jutten, M.H. Starmans, and M.C. de Jong The autophagy associated gene, ULK1, promotes tolerance to chronic and acute hypoxia Radiother Oncol 108 2013 529 534
84. Y.-L. Hu, M. DeLay, A. Jahangiri, A.M. Molinaro, S.D. Rose, and W.S. Carbonell Hypoxia-induced autophagy promotes tumor cell survival and adaptation to antiangiogenic treatment in glioblastoma Cancer Res 72 2012 1773 1783
85. M.A. Peña-Rico, M.N. Calvo-Vidal, R. Villalonga-Planells, F. Martínez-Soler, P. Giménez-Bonafé, and À. Navarro-Sabaté TP53 induced glycolysis and apoptosis regulator (TIGAR) knockdown results in radiosensitization of glioma cells Radiother Oncol 101 2011 132 139
86. C.H.M.A. Ramaekers, T. van den Beucken, A. Meng, S. Kassam, J. Thoms, and R.G. Bristow Hypoxia disrupts the Fanconi anemia pathway and sensitizes cells to chemotherapy through regulation of UBE2T Radiother Oncol 101 2011 190 197
87. S.M. Harding, C. Coackley, and R.G. Bristow ATM-dependent phosphorylation of 53BP1 in response to genomic stress in oxic and hypoxic cells Radiother Oncol 99 2011 307 312
88. B.S. Sørensen, M. Busk, N. Olthof, E.J. Speel, M.R. Horsman, and J. Alsner Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells Radiother Oncol 108 2013 500 505
89. H. Stegeman, P.N. Span, P.F.J.W. Rijken, S.C. Cockx, D.L. Wheeler, and M. Iida Dasatinib inhibits DNA Repair after radiotherapy specifically in pSFK-expressing tumor areas in head and neck xenograft tumors Transl Oncol 6 2013 413 419
90. M.M. Nijkamp, P.N. Span, J. Bussink, and J.H.A.M. Kaanders Interaction of EGFR with the tumour microenvironment: implications for radiation treatment Radiother Oncol 108 2013 17 23
91. R.C. Meena, N. Kumar, S. Nath, and A. Chakrabarti Homologous recombination is activated at early time points following exposure to cobalt chloride induced hypoxic conditions in Saccharomyces cerevisiae Indian J Microbiol 52 2012 209 214
92. R. Kumareswaran, O. Ludkovski, A. Meng, J. Sykes, M. Pintilie, and R.G. Bristow Chronic hypoxia compromises repair of DNA double-strand breaks to drive genetic instability J Cell Sci 125 2012 189 199
93. Y. Kim, Q. Lin, D. Zelterman, and Z. Yun Hypoxia-regulated delta-like 1 homologue enhances cancer cell stemness and tumorigenicity Cancer Res 69 2009 9271 9280
94. M.M. Saller, W.C. Prall, D. Docheva, V. Schönitzer, T. Popov, and D. Anz Increased stemness and migration of human mesenchymal stem cells in hypoxia is associated with altered integrin expression Biochem Biophys Res Commun 423 2012 379 385
95. K. Matsumoto, T. Arao, K. Tanaka, H. Kaneda, K. Kudo, and Y. Fujita MTOR signal and hypoxia-inducible factor-1 alpha regulate CD133 expression in cancer cells Cancer Res 69 2009 7160 7164
96. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck J Clin Oncol 27 2009 1992 1998
97. M.L. Gillison, W.M. Koch, R.B. Capone, M. Spafford, W.H. Westra, and L. Wu Evidence for a causal association between human papillomavirus and a subset of head and neck cancers J Natl Cancer Inst 92 2000 709 720
98. S. Marur, G. D'Souza, W.H. Westra, and A.A. Forastiere HPV-associated head and neck cancer: a virus-related cancer epidemic Lancet Oncol 11 2010 781 789
99. K.K. Ang, J. Harris, R. Wheeler, R. Weber, D.I. Rosenthal, and P.F. Nguyen-Tân Human papillomavirus and survival of patients with oropharyngeal cancer N Engl J Med 363 2010 24 35
100. T. Rieckmann, S. Tribius, T.J. Grob, F. Meyer, C.-J. Busch, and C. Petersen HNSCC cell lines positive for HPV and p16 possess higher cellular radiosensitivity due to an impaired DSB repair capacity Radiother Oncol 107 2013 242 246
101. C.-J. Busch, M. Kriegs, S. Laban, S. Tribius, R. Knecht, and C. Petersen HPV-positive HNSCC cell lines but not primary human fibroblasts are radiosensitized by the inhibition of Chk1 Radiother Oncol 108 2013 495 499
102. P. Lassen, J.G. Eriksen, S. Hamilton-Dutoit, T. Tramm, J. Alsner, and J. Overgaard HPV-associated p16-expression and response to hypoxic modification of radiotherapy in head and neck cancer Radiother Oncol 94 2010 30 35
103. C. Fakhry, and M.L. Gillison Clinical implications of human papillomavirus in head and neck cancers J Clin Oncol 24 2006 2606 2611
104. P. Lassen, J.G. Eriksen, A. Krogdahl, M.H. Therkildsen, B.P. Ulhøi, and M. Overgaard The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial Radiother Oncol 100 2011 49 55
105. J. Overgaard Hypoxic modification of radiotherapy in squamous cell carcinoma of the head and neck-a systematic review and meta-analysis Radiother Oncol 100 2011 22 32
106. C. Lin, Y. Yu, H.-G. Zhao, A. Yang, H. Yan, and Y. Cui Combination of quercetin with radiotherapy enhances tumor radiosensitivity in vitro and in vivo Radiother Oncol 104 2012 395 400
107. M.A. Schmidt, C. Förtsch, M. Schmidt, T.T. Rau, R. Fietkau, and L.V. Distel Circulating regulatory T cells of cancer patients receiving radiochemotherapy may be useful to individualize cancer treatment Radiother Oncol 104 2012 131 138
108. S.C. Formenti, and S. Demaria Systemic effects of local radiotherapy Lancet Oncol 10 2009 718 726
109. W.H. McBride, C.-S. Chiang, J.L. Olson, C.-C. Wang, J.-H. Hong, and F. Pajonk A sense of danger from radiation Radiat Res 162 2004 1 19
110. P. Schildkopf, B. Frey, O.J. Ott, Y. Rubner, G. Multhoff, and R. Sauer Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages Radiother Oncol 101 2011 109 115
111. I. Eke, E. Dickreuter, and N. Cordes Enhanced radiosensitivity of head and neck squamous cell carcinoma cells by β1 integrin inhibition Radiother Oncol 104 2012 235 242
112. I. Eke, and N. Cordes Radiobiology goes 3D: how ECM and cell morphology impact on cell survival after irradiation Radiother Oncol 99 2011 271 278
113. M.H. Barcellos-Hoff, C. Park, and E.G. Wright Radiation and the microenvironment - tumorigenesis and therapy Nat Rev Cancer 5 2005 867 875
114. N. Cordes, and D. Van Beuningen Cell adhesion to the extracellular matrix protein fibronectin modulates radiation-dependent G2 phase arrest involving integrin-linked kinase (ILK) and glycogen synthase kinase-3β (GSK-3β) in vitro Br J Cancer 88 2003 1470 1479
115. N. Cordes, and V. Meineke Cell adhesion-mediated radioresistance (CAM-RR). Extracellular matrix-dependent improvement of cell survival in human tumor and normal cells in vitro Strahlenther Onkol 179 2003 337 344
116. M. Dimitrijevic-Bussod, V.S. Balzaretti-Maggi, and D.M. Gadbois Extracellular matrix and radiation G1 cell cycle arrest in human fibroblasts Cancer Res 59 1999 4843 4847
117. M. Mimeault, and S.K. Batra Hypoxia-inducing factors as master regulators of stemness properties and altered metabolism of cancer- and metastasis-initiating cells J Cell Mol Med 17 2013 30 54
118. R.P. Hill, D.T. Marie-Egyptienne, and D.W. Hedley Cancer stem cells, hypoxia and metastasis Semin Radiat Oncol 19 2009 106 111
119. B. Das, R. Tsuchida, D. Malkin, G. Koren, S. Baruchel, and H. Yeger Hypoxia enhances tumor stemness by increasing the invasive and tumorigenic side population fraction Stem Cells 26 2008 1818 1830
120. L.S.Y. Nanduri, M. Maimets, S.A. Pringle, M. van der Zwaag, R.P. van Os, and R.P. Coppes Regeneration of irradiated salivary glands with stem cell marker expressing cells Radiother Oncol 99 2011 367 372
121. J. Mihatsch, M. Toulany, P.M. Bareiss, S. Grimm, C. Lengerke, and R. Kehlbach Selection of radioresistant tumor cells and presence of ALDH1 activity in vitro Radiother Oncol 99 2011 300 306
122. J.P. Medema, and L. Vermeulen Microenvironmental regulation of stem cells in intestinal homeostasis and cancer Nature 474 2011 318 326
123. L.S. Mortensen, J. Johansen, J. Kallehauge, H. Primdahl, M. Busk, and P. Lassen FAZA PET/CT hypoxia imaging in patients with squamous cell carcinoma of the head and neck treated with radiotherapy: results from the DAHANCA 24 trial Radiother Oncol 105 2012 14 20
124. M.J. Nyflot, P.M. Harari, S. Yip, S.B. Perlman, and R. Jeraj Correlation of PET images of metabolism, proliferation and hypoxia to characterize tumor phenotype in patients with cancer of the oropharynx Radiother Oncol 105 2012 36 40
125. D. Zips, K. Zöphel, N. Abolmaali, R. Perrin, A. Abramyuk, and R. Haase Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer Radiother Oncol 105 2012 21 28
126. L.-B.-A. Tran, A. Bol, D. Labar, B. Jordan, J. Magat, and L. Mignion Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry Radiother Oncol 105 2012 29 35
127. K.M. Ovrebø, T. Hompland, B. Mathiesen, and E.K. Rofstad Assessment of hypoxia and radiation response in intramuscular experimental tumors by dynamic contrast-enhanced magnetic resonance imaging Radiother Oncol 102 2012 429 435
128. L.S. Mortensen, M. Busk, M. Nordsmark, S. Jakobsen, J. Theil, and J. Overgaard Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study Radiother Oncol 99 2011 418 423
129. S.M. Bentzen, and V. Grégoire Molecular imaging-based dose painting: a novel paradigm for radiation therapy prescription Semin Radiat Oncol 21 2011 101 110
130. A. Søvik, E. Malinen, and D.R. Olsen Strategies for biologic image-guided dose escalation: a review Int J Radiat Oncol Biol Phys 73 2009 650 658